Related Experiment Videos
Summary
Focal elastosis in primary breast cancer showed no clear link to recurrence or death. However, estrogen-receptor activity appears to be a more reliable prognostic indicator for breast cancer patients.
Area of Science:
- Oncology
- Pathology
- Biomarkers
Background:
- Accurate prognostic factors are crucial for managing primary operable breast cancer.
- Assessing tumor characteristics like elastosis and estrogen-receptor status aids in predicting patient outcomes.
Purpose of the Study:
- To investigate the prognostic value of focal elastosis in primary operable breast cancer.
- To determine the association between elastosis, estrogen-receptor activity, and patient outcomes (recurrence and death).
Main Methods:
- Follow-up of 165 patients with primary operable breast cancer for up to 60 months.
- Determination of focal elastosis and estrogen-receptor activity, alongside tumor size and lymph node status.
- Life table analysis to compare risks of recurrence and death across subgroups.
Main Results:
- No association found between elastosis and patient age, menstrual status, or lymph node characteristics.
- A trend of larger tumors exhibiting less elastosis was observed.
- Significant association noted between elastosis grade and estrogen-receptor activity presence/absence.
- Focal elastosis alone was a poor prognostic factor.
Conclusions:
- Estrogen-receptor activity demonstrated a stronger suggestion as a prognostic indicator compared to focal elastosis.
- Further research into estrogen-receptor activity's role in breast cancer prognosis is warranted.